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Öz
Abstract
Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood. 
Central nervous system is the most frequent place of both at the onset and 
relapse of the disease, but orbital involvement is rarely seen. A seven-year-old girl 
diagnosed with high risk ALL and Turkish ALL-Berlin Frankfurt Münster (BFM)-2000 
high risk group treatment was given. However, after induction and consolidation 
treatments, before the maintenance treatment she had blindness in her right eye. 
Ophthalmologic examination her visual acuity was fingers to count in two meters. 
In her right eye there was exudative retinal detachment and her orbital magnetic 
resonance imaging (MRI) showed that, there was a mass lesion in the posterior of 
right orbital globe, on the neighbourhood of optic disc, consistent with metastasis. 
After ALL-REZ-BFM-2002 relapse protocol treatments and radiotherapy her visual 
acuity was increased to 6/10. In control orbital MRI regression of mass lesion size 
was established. Bone marrow transplantation was planned. Orbital involvement 
is rarely seen in leukemia, but it is responsive to chemotherapy and radiotherapy 
combination.
Akut lenfoblastik lösemi (ALL) çocukluk çağının en sık görülen malignitesidir. Tanı 
anında ve relaps olgularda santral sinir sistemi tutulumu sık görülmesine karşın 
orbital tutulum nadiren görülmektedir. Yedi yaşında kız hasta kliniğimizde yüksek 
risk ALL tanısı alarak Türk ALL-Berlin Frankfurt Münster (BFM)-2000 yüksek risk 
grubu protokol tedavisini almakta iken; indüksiyon ve konsolidasyon tedavileri 
ardından, idame tedavisi öncesi sağ gözde görememe şikayeti ile başvurdu. 
Hastanın oftalmolojik muayenesinde görme keskinliği iki metreden parmak sayma 
şeklindeydi. Hastanın sağ gözünde retinal dekolman mevcuttu ve orbital manyetik 
rezonans görüntülemesinde (MRG) sağ orbita arkasında metastaz ile uyumlu 
kitle lezyonu saptandı. Hastaya ALL-REZ-BFM-2002 relaps protokol tedavisi ve 
radyoterapi uygulandıktan sonra hastanın görme keskinliği 6/10 olarak saptandı 
ve kontrol MRG görüntülemesinde kitle lezyonda küçülme gözlendi. Hastaya kemik 
iliği nakli yapılması planlandı. Lösemide orbital tutulum nadiren görülmektedir, 
ancak bu durum kemoterapi ve radyoterapi kombinasyonuna yanıt vermektedir.
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Introduction
Acute lymphoblastic leukemia (ALL) is the most 
common malignancy of childhood, which could be 
curable in 80% with intensive chemotherapy protocols 
(1). Central nervous system is the most frequent place 
of both at the onset and relapse of the disease (2). 
Orbital involvement is rarely seen. In literature, with 
25 isolated orbital relapse case series it is indicated 
that isolated relapse cases were treated successfully 
with chemotherapy and radiotherapy combination 
(3). We report a high risk ALL case with isolated orbital 
relapse that was treated with Turkish ALL-Berlin 
Frankfurt Münster (TRALL-BFM)-2000 protocol.
Case Report
A seven-year-old girl administered to our 
clinic with the symptoms of fever and abdominal 
pain. In her physical examination, there were 
widespread lymphadenopathy, gingival hypertrophy, 
hepatomegaly with 6 cm and splenomegaly with 5 cm. 
Laboratory results were as follow; hemoglobin: 6.5 g/
dL, platelet: 139 K/UL, white blood cell count: 611 K/
UL, lactate dehydrogenase: 1961 U/L, uric acid: 13.6 
mg/dL. There was L1 type lymphoblast in peripheral 
smear 98% and in bone marrow aspiration 85%. With 
flow-cytometry results, she was diagnosed with pre B 
cell ALL. BCR/ABL fusion was detected in cytogenetic 
analysis. She was diagnosed with high-risk group 
due to high white blood cell count and Philadelphia 
chromosome positivity. TRALL-BFM-2000 high risk 
group treatment was started. There was not any 
lymphoblast in her cerebrospinal fluid (CSF).
After induction and consolidation treatments, 
before the maintenance treatment blindness 
developed in her right eye. Ophthalmologic 
examination her visual acuity was fingers to count 
in two meters. In her right eye there was exudative 
retinal detachment and metastatic lesion around 
optic nerve. Bilaterally intraocular pressure and 
ophthalmologic examination of left eye were normal 
(Figure 1). Cranial magnetic resonance imagining 
(MRI) was normal, but orbital MRI showed that there 
was a mass lesion in the posterior of right orbital 
globe, on the neighbourhood of optic disc with 
dimensions of 6x1 cm consistent with metastasis. Her 
CSF and bone marrow aspiration, which were done for 
relapse, were normal. Biopsy could not be performed 
from mass lesion. Patient age and primary sickness 
were considered and diagnosed as ALL relapse. After 
ALL-REZ-BFM-2002 relapse protocol F1, F2 and R2 
block treatments; radiotherapy and bone marrow 
transplantation from unrelated donor was planned. 
At the end of R2 block chemotherapy, her visual acuity 
was increased to 6/10 and in her ophthalmologic 
examination decrease in retinal detachment was 
detected. In control orbital MRI regression of mass 
lesion size was established.
Informed consent was taken from patient family. 
Discussion
In ALL patients, like our case, hyperleukocytosis 
at administration, Philadelphia chromosome 
positivity show poor prognosis. The most frequent 
extramedullary involvement is seen in central 
nervous system (2). Orbital involvement is rarely 
seen in leukemia patients. In differential diagnosis 
of exudative detachment there are uveal fusion 
syndrome, choroidopathy, Harada syndrome, choroid 
detachment, choroidal neovascularisation, and 
severe intraocular hypotonic but with consideration 
of patients age and primary illness it was thought with 
orbital relapse. In ALL patients who were in remission 
period, 25 isolated case series were reported. In the 
10 of patients were on treatment, 15 of patients after 
completion of treatment. They administered with 
orbital symptoms. Their age was between 1 to 13. An 
average of 29 months after diagnosis, ocular relapse 
was detected, and long-term survival was long in the 
group who took both chemotherapy and radiotherapy. 
In one patient who took low dose local radiotherapy, 
resistance of leukemic cells was developed, and 
enucleation was performed. In this case series, it was 
reported that with local radiotherapy and systemic 
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Figure 1. a, b) Right optic nerve invasion cause retinal 
detachment c, d) Left eye (normal) e) Serous retinal detachment 
of right eye f) Right eye, after treatment g) Left eye (normal)
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chemotherapy treatment was successfully achieved. 
Also, after treatment prognosis was reports as better 
in isolated orbital relapse group than central nervous 
system and bone marrow relapse groups (3). First case 
with isolates orbital ALL relapse administered with 
unilaterally retinal detachment and unresponsive 
to medical treatment painful glaucoma. Patient was 
treated successfully with systemic and intrathecal 
chemotherapy (4). A 17-year-old patient, who was 
followed as leukemia, administered with retinal 
detachment and choroidal haemorrhage. Patient 
was treated with prednisolone, topical steroid and 
atropine but while when she administered her CSF 
and bone marrow was clean, after five months bone 
marrow relapse was seen (5). In our country, Azık et 
al. (6) reported an eight-year-old ALL patient, who had 
sudden visual loss in remission period. In this case 
there was also isolated orbital relapse was detected 
without bone marrow and central nervous system 
relapse. Retinal detachment resulted with sudden 
visual loss (6). Our case was high risk ALL patient and 
isolated orbital relapse was seen. From 10 months 
of diagnosis, orbital involvement was seen. After 
systemic chemotherapy leukemic infiltration and 
retinal detachment decreased.
As a result, orbital involvement is rarely seen 
in leukemia, but it is responsive to chemotherapy 
and radiotherapy combination. Leukemia patients, 
especially high-risk ones, should be screened with 
ophthalmologic examinations both at diagnosis and 
after treatment.
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